Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy
Abstract Canine drug-resistant epilepsy is a prevailing issue in veterinary neurology. Alternative or additional treatment with cannabinoids is showing promising results in seizure management. A crucial component of the endocannabinoid system, cannabinoid receptor type 1 (CB1R), is heavily involved...
Main Authors: | D. Kostic, M. Nowakowska, J. Freundt Revilla, F. Attig, K. Rohn, F. Gualtieri, W. Baumgärtner, H. Potschka, A. Tipold |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-29868-3 |
Similar Items
-
Neurostimulation as a method of treatment and a preventive measure in canine drug-resistant epilepsy: current state and future prospects
by: Nowakowska, M, et al.
Published: (2022) -
Cell type-specific long-term plasticity at glutamatergic synapses onto hippocampal interneurons expressing either parvalbumin or CB1 cannabinoid receptor.
by: Nissen, W, et al.
Published: (2010) -
Cannabinoids in the Treatment of Epilepsy: A Review
by: Daniel Zhou, et al.
Published: (2021-10-01) -
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
by: Irene B. Maroto, et al.
Published: (2023-04-01) -
Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse
by: Rodrigo Zamith Cunha, et al.
Published: (2023-11-01)